MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/17/2026, 05:12 AM (Berlin time), refresh in progress.

Elevance Health Stock

Elevance Health Inc.

ELVNYSEKern
US$428.26
-0.0% today

Company data

Sector
Healthcare
Industry
Medical - Healthcare Plans
Country
United States
CEO
Gail Koziara Boudreaux
Employees
96,615
Market cap
$92.9 B
IPO
30/10/2001

Elevance Health Inc., trading under the ticker symbol ELV, operates in the healthcare/medical sector within the healthcare plans industry. Founded in 1944, the U.S.-based company serves approximately 118 million people as a comprehensive healthcare provider and is headquartered in Indianapolis. Following its…

AI-generated company profile based on the figures on this page, last updated on 01/10/2026. Not investment advice.

Elevance Health stock: price history

16/10/25+23 %16/10/26

1D

-0.0%

1W

+3.8%

1M

+3.8%

6M

+32.6%

YTD

+22.2%

1Y

+23.0%

2Y

-13.8%

5Y

+9.0%

10Y

+253.7%

Next earnings date

Next earnings date

21/10/2026 (in 4 days)

Volatility around earnings

~56% stronger price swings than usual

Pattern chart

Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 14/10/26. Not a buy or sell signal.Beta

What does this mean?

Double bottom

Bullish

The price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.

Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.

Elevance Health stock scores

  • Valuation

    Visible after free registration

  • Trend

    Visible after free registration

  • Quality

    Visible after free registration

  • Dividend

    Visible after free registration

  • Growth

    Visible after free registration

  • Insider

    Visible after free registration

  • Earnings

    Visible after free registration

  • Revisions

    Visible after free registration

  • Sentiment

    Visible after free registration

  • Short Pressure

    Visible after free registration

Register for free

Unlock all 11 scores

  • 5 credits free on registration
  • Access to virtual portfolios and watchlist
  • No credit card, no payment details needed
  • No subscription, no minimum term
  • Our own servers in Germany, no US cloud
Create account →

Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.

Business model & megatrends

Business model

Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.

Why this value? Details with Pro only.

1 more assignment (Enabler/Second row) Pro-only.

Elevance Health Inc. is a comprehensive healthcare provider primarily operating in the health insurance sector. The company offers solutions in medical care, digital health, pharmacy, and behavioral health, serving approximately 118 million people. With a focus on the Health Benefits segment, the company generates the majority of its revenues through insurance services, while the Carelon Services segment provides specialized healthcare services. The business model is characterized by high relevance in medical care delivery and a strong market presence.

Revenue model
Interest spread
Recurring revenue
High
Pricing power
Moderate
Moat
Wide
Moat type
Regulatory
Capital intensity
Low
Customer concentration
Unknown

Ask the agents about Elevance Health

Analyst assessment of Elevance Health

PRICE TARGET LOW

US$391.00

CONSENSUS

US$445.13

MEDIAN

US$460.00

PRICE TARGET HIGH

US$498.00

0

STRONG BUY

27

BUY

11

HOLD

0

SELL

0

STRONG SELL

38

TOTAL · Buy

As of: 12/10/2026

ANALYST FIRMRATINGACTIONDATE
GuggenheimBuymaintain12/10/2026
BarclaysOverweightmaintain07/10/2026
Leerink PartnersMarket Performmaintain17/07/2026
BernsteinOutperformmaintain17/07/2026
BarclaysOverweightmaintain16/07/2026
BairdNeutralmaintain16/07/2026
RBC CapitalSector Performmaintain16/07/2026
Wells FargoOverweightmaintain16/07/2026

Elevance Health stock metrics

P/E

19.03

P/B

2.08

EV/EBITDA

13.37

RETURN ON EQUITY

3.3%

NET MARGIN

2.9%

DEBT/EQUITY

0.69

DIVIDEND YIELD

1.6%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

99.8%

FLOAT SHARES

216,372,659

AVG. DAILY VOLUME (30D)

1,276,020

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Kaye Mark

OfficerGrant2,627–Spontaneous06/10/2026

Kaye Mark

OfficerTax settlement4,161386.43Spontaneous06/10/2026

Wessling Erin M

OfficerTax settlement255414.78Spontaneous04/09/2026

Wessling Erin M

OfficerTax settlement94405.84Spontaneous04/09/2026

Craig Ryan R

OfficerTax settlement144405.84Spontaneous04/09/2026
Page 1 / 5

Attention

Price since yesterday: -0.0%

Search (Google Trends)

18/0902/1017/10

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
Ninety One UK Ltd472,922-35,35830/09/2026
DAVENPORT & Co LLC384,435-57,50530/09/2026
Assenagon Asset Management S.A.152,374-147,00030/09/2026
FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND95,165-7,95730/09/2026
ZWJ INVESTMENT COUNSEL INC93,029+3,23430/09/2026
Page 1 / 3

Dividends & Stock splits

Dividends

EX-DATEPAY DATEAMOUNTYIELD
10/09/202625/09/2026US$1.721.6 %
10/06/202625/06/2026US$1.721.7 %
10/03/202625/03/2026US$1.722.4 %
05/12/202519/12/2025US$1.712.1 %
10/09/202525/09/2025US$1.712.2 %
Page 1 / 8

Stock splits

DATERATIO
01/06/20052:1

Smart Money

Register for free

Register now to see which funds are invested

  • 5 credits free on registration
  • Access to virtual portfolios and watchlist
  • No credit card, no payment details needed
  • No subscription, no minimum term
  • Our own servers in Germany, no US cloud
Create account →

Comparable stocks

Frequently asked questions about Elevance Health stock

What does Elevance Health do?

Elevance Health Inc. is a company in the Healthcare sector, Medical - Healthcare Plans industry, headquartered in United States.

The CEO is Gail Koziara Boudreaux, the company employs around 96,615 people.

The IPO was on 30/10/2001; the stock trades on NYSE under the ticker ELV.

What do analysts say about Elevance Health stock?

38 analysts rate the stock, the consensus is Buy (as of 12/10/2026).

The average price target is US$445.13, ranging from US$391.00 to US$498.00, with a median of US$460.00.

This is an external assessment, not a statement by Market Jury.

When does Elevance Health report next?

The next earnings date is 21/10/2026.

Around past earnings, price swings were roughly 56% stronger than usual.

Does Elevance Health pay a dividend?

Yes. The last dividend was US$1.72 per share, ex-date 10/09/2026, paid on 25/09/2026.

The dividend yield is 1.6% (as of 30/06/2026).

Which stocks are comparable to Elevance Health?

Comparable stocks include UnitedHealth Group, CVS Health, Cigna, Humana, Centene, Molina Healthcare and Oscar Health.

How can I get Elevance Health stock analyzed?

Clicking "Analyze stock" lets five strategies assess Elevance Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.